ArticleJournal of surgical oncology2025

Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT Study.

Brenda Diergaarde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.